FibroGen, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

FibroGen, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated December 2, 2025
Public ProfileLinkedInLinkedIn Profile

FibroGen, Inc.

Employees87
Revenue$29.6M
Market Cap44.6M

Industry & Market

Primary Industry
research
All Industries
researchbiotechnology
Location
San Francisco, California, United States
Public Trading
NASDAQ: FGEN

Funding Information

Annual Revenue
$29,621,000
Publicly traded company

Headcount Distribution

Total Employees
87
Departments
19

By Department

Department Breakdown

Operations
Information Technology
Business Development
Finance
Accounting
Engineering
Others

Keywords & Focus Areas

anemiachronic kidney diseasefibrotic diseaseduchenne muscular dystrophypancreatic cancerhifphiantictgfbiotechnologylife sciencesbiotechnology: pharmaceutical preparationshealth carebiotechnology researchpharmaceutical partnershipsmarket researchbiotech drugsanemia treatmenthif prolyl hydroxylase inhibitorbiopharmaceutical researchoncology biotechhealthcare+10 more
30 total keywords

Overview

FibroGen, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 1993. The company focuses on discovering, developing, and commercializing innovative therapeutics for serious medical needs, particularly in oncology and anemia-related conditions. It utilizes advanced science, including hypoxia-inducible factor (HIF) biology, to create first-in-class medicines aimed at treating life-threatening diseases such as metastatic pancreatic cancer and anemia associated with chronic kidney disease.

The lead product, Roxadustat, is an oral small molecule approved in multiple countries for treating anemia in chronic kidney disease patients. The company is also developing monoclonal antibodies FG-3165 and FG-3175 for solid tumors and has plans for Pamrevlumab, which represents a strategic shift in its therapeutic focus. FibroGen collaborates with major pharmaceutical firms like AstraZeneca and Regeneron Pharmaceuticals to advance its research and clinical trials, enhancing its global market presence.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
FibroGen, Inc.
Headquarters
409 Illinois St, San Francisco, CA 94158, US
Founded
1993
Industry
research, biotechnology

Technology Stack

Analytics & Tracking

Not found

Social & Marketing

Not found

Database & Backend

OneTrust

Cloud & Infrastructure

Atlassian CloudCloudFlare HostingCloudflare DNS

Productivity

Not found

Compare similar companies to FibroGen, Inc.

Compare insights from companies similar to FibroGen, Inc., focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xx
$16320134Private-7259
x
xxxxxxxx
$9810581Private-6197
x
xxxxxxx
$3140189Private-24
xxxx
xxxxxxxx
$2704445Private-4700
xxxxx
xxxxxxxx
$1755128Private-6708
xxxxxxxxxx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free